Daniel D. Long, SVP, Drug Discovery at Septerna, Inc. (SEPN), sold 15,000 shares at $35.10 ($533K) on 2026-06-22, disclosed to the SEC on 2026-06-24.
Scheduled sale ($533k) by SVP, Drug Discovery under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.10 | 8,000 | $281K | 52.7% |
| 2 | $35.97 | 7,000 | $252K | 47.3% |
| Total | $35.51 avg | 15,000 | $533K | 100% |
| Filing → |
| SEPN | SELL | 2026-07-02 | $115K | — | Filing → |
| SEPN | SELL | 2025-11-13 | $126K | — | Filing → |